SIG Brokerage’s AstraZeneca AZN Stock Holding History

SIG Brokerage’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,691	Closed	-$259K	–	677
2025 Q3	$259K	Sell	1,691 -9,595	-85%	-$1.45M	0.01%	633
2025 Q2	$1.58M	Buy	+11,286	New	+$1.58M	0.04%	265

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SIG Brokerage's AZN Position: Q4 2025 in Review

SIG Brokerage sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 1,691 shares — an estimated $259K sold.

SIG Brokerage first reported a position in AZN in Q2 2025 and held it in 2 quarters. The position peaked at $1.58M in Q2 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

SIG Brokerage reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
SIG Brokerage sold 1,691 AstraZeneca shares in Q4 2025, an estimated $259K.
SIG Brokerage first reported a position in AstraZeneca in Q2 2025 and held it in 2 quarters.
SIG Brokerage's AstraZeneca position peaked at $1.58M in Q2 2025.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on SIG Brokerage's 13F filing for Q4 2025, filed 17 Feb 2026.